PMID- 28033431 OWN - NLM STAT- MEDLINE DCOM- 20170705 LR - 20220409 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 11 IP - 12 DP - 2016 TI - Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma. PG - e0169232 LID - 10.1371/journal.pone.0169232 [doi] LID - e0169232 AB - Long non-coding RNA (lncRNA) plays an important role in tumorigenesis. However, the expression pattern and function of lncRNAs in laryngeal squamous cell carcinoma (LSCC) are still unclear. To investigate the aberrantly expressed lncRNAs and mRNAs in advanced LSCC, we screened lncRNA and mRNA expression profiles in 9 pairs of primary Stage IVA LSCC tissues and adjacent non-neoplastic tissues by lncRNA and mRNA integrated microarrays. Gene Ontology and pathway analysis were performed to find out the significant function and pathway of the differentially expressed mRNAs, gene-gene functional interaction network and ceRNA network were constructed to select core mRNAs, and lncRNA-mRNA expression correlation network was built to identify the interactions between lncRNA and mRNA. qRT-PCR was performed to further validate the expressions of selected lncRNAs and mRNAs in advanced LSCC. We found 1459 differentially expressed lncRNAs and 2381 differentially expressed mRNAs, including 846 up-regulated lncRNAs and 613 down-regulated lncRNAs, 1542 up-regulated mRNAs and 839 down-regulated mRNAs. The mRNAs ITGB1, HIF1A, and DDIT4 were selected as core mRNAs, which are mainly involved in biological processes, such as matrix organization, cell cycle, adhesion, and metabolic pathway. LncRNA-mRNA expression correlation network showed LncRNA NR_027340, MIR31HG were positively correlated with ITGB1, HIF1A respectively. LncRNA SOX2-OT was negatively correlated with DDIT4. qRT-PCR further validated the expression of these lncRNAs and mRNAs. The work provides convincing evidence that the identified lncRNAs and mRNAs are potential biomarkers in advanced LSCC for further future studies. FAU - Feng, Ling AU - Feng L AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. FAU - Wang, Ru AU - Wang R AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. FAU - Lian, Meng AU - Lian M AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. FAU - Ma, Hongzhi AU - Ma H AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. FAU - He, Ning AU - He N AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Department of Head and Neck Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. FAU - Liu, Honggang AU - Liu H AD - Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing, China. FAU - Wang, Haizhou AU - Wang H AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. FAU - Fang, Jugao AU - Fang J AD - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. AD - Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing, China. AD - Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing, China. LA - eng PT - Journal Article DEP - 20161229 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (RNA, Long Noncoding) RN - 0 (RNA, Messenger) SB - IM MH - Carcinoma, Squamous Cell/*genetics/*pathology MH - Computational Biology/*methods MH - Female MH - *Gene Expression Profiling MH - Gene Ontology MH - Gene Regulatory Networks MH - Humans MH - Laryngeal Neoplasms/*genetics/*pathology MH - Male MH - Middle Aged MH - RNA, Long Noncoding/*genetics MH - RNA, Messenger/genetics PMC - PMC5199101 COIS- The authors have declared that no competing interests exist. EDAT- 2016/12/30 06:00 MHDA- 2017/07/06 06:00 PMCR- 2016/12/29 CRDT- 2016/12/30 06:00 PHST- 2016/09/27 00:00 [received] PHST- 2016/12/13 00:00 [accepted] PHST- 2016/12/30 06:00 [entrez] PHST- 2016/12/30 06:00 [pubmed] PHST- 2017/07/06 06:00 [medline] PHST- 2016/12/29 00:00 [pmc-release] AID - PONE-D-16-38119 [pii] AID - 10.1371/journal.pone.0169232 [doi] PST - epublish SO - PLoS One. 2016 Dec 29;11(12):e0169232. doi: 10.1371/journal.pone.0169232. eCollection 2016.